Volume | 1,277,931 |
|
|||||
News | - | ||||||
Day High | 0.9303 | Low High |
|||||
Day Low | 0.805 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.81 | 0.805 | 0.9303 | 0.8973 | 0.8241 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3,149 | 1,277,931 | $ 0.8851153 | $ 1,131,116 | - | 0.60 - 1.71 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:57:43 | 1 | $ 0.9099 | USD |
Citius Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
141.59M | 159.09M | - | 0 | -33.69M | -0.21 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Citius Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.779 | 0.9303 | 0.7247 | 0.7925433 | 621,225 | 0.1111 | 14.26% |
1 Month | 0.80 | 0.9303 | 0.65 | 0.747826 | 586,360 | 0.0901 | 11.26% |
3 Months | 0.77 | 0.9303 | 0.60 | 0.7236465 | 665,177 | 0.1201 | 15.60% |
6 Months | 0.6898 | 0.9303 | 0.60 | 0.7427041 | 595,581 | 0.2003 | 29.04% |
1 Year | 1.00 | 1.71 | 0.60 | 1.06 | 1,054,600 | -0.1099 | -10.99% |
3 Years | 1.8435 | 4.56 | 0.60 | 1.97 | 2,060,803 | -0.9534 | -51.72% |
5 Years | 1.50 | 4.56 | 0.40 | 1.85 | 2,344,475 | -0.6099 | -40.66% |
Citius Pharmaceuticals Description
Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome. |